0001415889-24-001783.txt : 20240124
0001415889-24-001783.hdr.sgml : 20240124
20240124202646
ACCESSION NUMBER: 0001415889-24-001783
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240124
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cui Xiangmin
CENTRAL INDEX KEY: 0001487815
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41925
FILM NUMBER: 24558340
MAIL ADDRESS:
STREET 1: NO. 14 EAST HUSHAN ROAD
STREET 2: TAI'AN CITY
CITY: SHANDONG
STATE: F4
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Decheng Capital Global Life Sciences Fund IV, L.P.
CENTRAL INDEX KEY: 0001834150
ORGANIZATION NAME:
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41925
FILM NUMBER: 24558342
BUSINESS ADDRESS:
STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED
STREET 2: UGLAND HOUSE, P.O. BOX 309
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 345-949-8066
MAIL ADDRESS:
STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED
STREET 2: UGLAND HOUSE, P.O. BOX 309
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Decheng Capital Management IV (Cayman), LLC
CENTRAL INDEX KEY: 0001843384
ORGANIZATION NAME:
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41925
FILM NUMBER: 24558341
BUSINESS ADDRESS:
STREET 1: P.O. BOX 309, UGLAND HOUSE
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: (650) 233-0688
MAIL ADDRESS:
STREET 1: P.O. BOX 309, UGLAND HOUSE
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CG Oncology, Inc.
CENTRAL INDEX KEY: 0001991792
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 371611499
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 419-6203
MAIL ADDRESS:
STREET 1: 400 SPECTRUM CENTER DRIVE
STREET 2: SUITE 2040
CITY: IRVINE
STATE: CA
ZIP: 92618
3
1
form3-01252024_010140.xml
X0206
3
2024-01-24
0
0001991792
CG Oncology, Inc.
CGON
0001834150
Decheng Capital Global Life Sciences Fund IV, L.P.
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN
E9
KY1-1104
CAYMAN ISLANDS
false
false
true
false
0001843384
Decheng Capital Management IV (Cayman), LLC
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN
E9
KY1-1104
CAYMAN ISLANDS
0
0
1
0
0001487815
Cui Xiangmin
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN
E9
KY1-1104
CAYMAN ISLANDS
0
0
1
0
Common Stock
930612
D
Series C Preferred Stock
Common Stock
906646
D
Series E Preferred Stock
Common Stock
2259851
D
Series F Preferred Stock
Common Stock
461701
D
These reportable securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. ("Fund IV"). Decheng Capital Management IV (Cayman), LLC ("GP IV") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. All share numbers reported in this Form 3 reflect a 1-for-9.535 reverse stock split for the Issuer's common stock, effected by the Issuer on January 16, 2024.
Decheng Capital Global Life Sciences Fund IV, L.P., By Decheng Capital Management IV (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
2024-01-24
Decheng Capital Management IV (Cayman), LLC, By /s/ Xiangmin Cui, Manager
2024-01-24
/s/ Xiangmin Cui
2024-01-24